Jump Trading’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,700
Closed -$703K 466
2018
Q2
$703K Sell
12,700
-9,400
-43% -$508K 0.06% 163
2018
Q1
$1.4M Sell
22,100
-3,000
-12% -$193K 0.13% 130
2017
Q4
$1.54M Buy
25,100
+21,400
+578% +$1.34M 0.2% 91
2017
Q3
$236K Sell
3,700
-30,100
-89% -$1.76M 0.04% 195
2017
Q2
$1.88M Buy
33,800
+29,200
+635% +$1.59M 0.28% 75
2017
Q1
$250K Buy
+4,600
New +$252K 0.08% 129
2016
Q3
Sell
-4,300
Closed -$316K 229
2016
Q2
$316K Buy
4,300
+4,232
+6,224% +$299K 0.01% 523
2016
Q1
$434K Buy
68
+33
+94% +$2.08K 0.02% 362
2015
Q4
$241K Sell
35
-411
-92% -$27.2K 0.01% 643
2015
Q3
$5.84M Sell
446
-7,654
-94% -$486K 0.06% 39
2015
Q2
$539K Buy
8,100
+1,100
+16% +$72.5K 0.01% 450
2015
Q1
$452K Buy
7,000
+5,800
+483% +$363K 0.01% 438
2014
Q4
$71K Sell
1,200
-6,300
-84% -$355K ﹤0.01% 828
2014
Q3
$384K Buy
7,500
+2,100
+39% +$105K 0.01% 454
2014
Q2
$262K Sell
5,400
-3,400
-39% -$168K 0.01% 454
2014
Q1
$457K Sell
8,800
-16,300
-65% -$867K 0.02% 376
2013
Q4
$1.33M Sell
25,100
-4,900
-16% -$250K 0.12% 185
2013
Q3
$1.39M Buy
30,000
+14,900
+99% +$654K 0.22% 131
2013
Q2
$675K Buy
+15,100
New +$656K 0.27% 94

Other funds holding BMY

Jump Trading's BMY Position: Q2 2020 in Review

Jump Trading sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 3,878 shares — an estimated $216K sold.

Jump Trading first reported a position in BMY in Q2 2013 and held it in 14 quarters. The position peaked at $786K in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Jump Trading reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
  • Jump Trading sold 3,878 Bristol-Myers Squibb shares in Q2 2020, an estimated $216K.
  • Jump Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 14 quarters.
  • Jump Trading's Bristol-Myers Squibb position peaked at $786K in Q4 2019.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.